Summary of findings: Injection therapies vs placebo or no injection control: VISA‐A (score 0 to 100; 100 = no problems) After 3 months (6 to 12 months)
Summary of findings: Injection therapies showed no clear difference in VISA‐A (score 0 to 100; 100 = no problems) At 6 weeks compared with placebo or no injection control (low certainty).
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Summary of findings: Injection therapies vs placebo or no injection control VISA‐A (score 0 to 100; 100 = no problems) At 6 weeks · individuals with an investigator‐reported diagnosis of Achilles tendinopathy (or related terminology, e.g.… Summary of findings: Injection therapies showed no clear difference in VISA‐A (score 0 to 100; 100 = no problems) At 6 weeks compared with placebo or no injection control (low certainty). Injection therapies for Achilles tendinopathy (2015) · Cochrane Headline outcomes only | MD 0.79 | 5 studies · 200 participants | Low |
Summary of findings: Injection therapies vs placebo or no injection control VISA‐A (score 0 to 100; 100 = no problems) At 3 months · individuals with an investigator‐reported diagnosis of Achilles tendinopathy (or related terminology, e.g.… Summary of findings: Injection therapies showed no clear difference in VISA‐A (score 0 to 100; 100 = no problems) At 3 months compared with placebo or no injection control (low certainty). Injection therapies for Achilles tendinopathy (2015) · Cochrane Headline outcomes only | no estimate extracted | 5 studies · 189 participants | Low |
Summary of findings: Injection therapies vs placebo or no injection control VISA‐A (score 0 to 100; 100 = no problems) After 3 months (6 to 12 months) · individuals with an investigator‐reported diagnosis of Achilles tendinopathy (or related terminology, e.g.… Summary of findings: Injection therapies showed no clear difference in VISA‐A (score 0 to 100; 100 = no problems) After 3 months (6 to 12… compared with placebo or no injection control (low certainty). Injection therapies for Achilles tendinopathy (2015) · Cochrane Headline outcomes only | MD 0.14 | 3 studies · 132 participants | Low |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Injection therapies for Achilles tendinopathy 2015 · Cochrane Headline outcomes only | Not reported | list not extracted yet | Not assessed |
Studies behind the findings
None of these reviews ties its included studies to this outcome in the data here. Cochrane reviews and reviews with headline outcomes only do not list their studies yet.
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.